TY - JOUR
T1 - Adipocyte proteome and secretome influence inflammatory and hormone pathways in glioma
AU - Almeida, J.
AU - Costa, J.
AU - Coelho, P.
AU - Cea, V.
AU - Galesio, M.
AU - Noronha, J. P.
AU - Diniz, M. S.
AU - Prudêncio, C.
AU - Soares, R.
AU - Sala, C.
AU - Fernandes, Rúben
N1 - info:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F80434%2F2011/PT#
info:eu-repo/grantAgreement/FCT/5876/147342/PT#
sem pdf conforme despacho.
Italian Government supported Sala C. with an AIRC grant n. 10807 and PNR-CNR Aging Program 2012-2014.
Fernandes R. is support by SAICT-POL/24325/2016 and SAICT-POL/24358/2016.
PY - 2019
Y1 - 2019
N2 - Gliomas represent the most common primary malignant brain tumors in adults, with an extremely poor prognosis. Among several risk factors, lifestyle was also recently identified as a major risk factor for the development of primary glioma. In the present study, we explore the relationship between obesity and glioma in a cellular model. Thus, we have study the influence of adipocytes secretome on glioma cell line GL261. Using the 3T3-L1 adipocyte cell line, and its conditioned medium (adipokines-enriched medium), we showed that adipocyte-released factors relate with glioma angiogenic, growth, hormones and metabolic behavior by MALDI-TOF-MS and proteomic array analysis. In a first view, STI1, hnRNPs and PGK1 are under expressed on CGl. Similarly, both carbonic anhydrase and aldose reductase are even suppressed in glioma cells that grown under adipokines-enriched environment. Contrariwise, RFC1, KIF5C, ANXA2, N-RAP and RACK1 are overexpressed in GL261 cell the in the presence of the adipokines-enriched medium. We further identified the factors that are released by adipocyte cells, and revealed that several pro-inflammatory and angiogenic factors, such as IL-6, IL-11, LIF, PAI-1, TNF-α, endocan, HGF, VEGF IGF-I, were secreted to the medium into a high extent, whereas TIMP-1 and SerpinE1 were under expressed on CGl. This study discloses an interesting in vitro model for the study of glioma biology under a “obesity” environment, that can be explored for the understanding of cancer cells biology, for the search of biomarkers, prognostic markers and therapeutic approaches.
AB - Gliomas represent the most common primary malignant brain tumors in adults, with an extremely poor prognosis. Among several risk factors, lifestyle was also recently identified as a major risk factor for the development of primary glioma. In the present study, we explore the relationship between obesity and glioma in a cellular model. Thus, we have study the influence of adipocytes secretome on glioma cell line GL261. Using the 3T3-L1 adipocyte cell line, and its conditioned medium (adipokines-enriched medium), we showed that adipocyte-released factors relate with glioma angiogenic, growth, hormones and metabolic behavior by MALDI-TOF-MS and proteomic array analysis. In a first view, STI1, hnRNPs and PGK1 are under expressed on CGl. Similarly, both carbonic anhydrase and aldose reductase are even suppressed in glioma cells that grown under adipokines-enriched environment. Contrariwise, RFC1, KIF5C, ANXA2, N-RAP and RACK1 are overexpressed in GL261 cell the in the presence of the adipokines-enriched medium. We further identified the factors that are released by adipocyte cells, and revealed that several pro-inflammatory and angiogenic factors, such as IL-6, IL-11, LIF, PAI-1, TNF-α, endocan, HGF, VEGF IGF-I, were secreted to the medium into a high extent, whereas TIMP-1 and SerpinE1 were under expressed on CGl. This study discloses an interesting in vitro model for the study of glioma biology under a “obesity” environment, that can be explored for the understanding of cancer cells biology, for the search of biomarkers, prognostic markers and therapeutic approaches.
KW - Adipo-proteomics
KW - GL261
KW - Glioma
KW - Obesity
UR - http://www.scopus.com/inward/record.url?scp=85055161093&partnerID=8YFLogxK
U2 - 10.1007/s11011-018-0327-y
DO - 10.1007/s11011-018-0327-y
M3 - Article
C2 - 30302719
AN - SCOPUS:85055161093
SN - 0885-7490
JO - Metabolic Brain Disease
JF - Metabolic Brain Disease
ER -